Three-quarters of patients survive five or more years; more than half of patients with<unk>  survive more than a decade after diagnosis. Patients who have a hemoglobin level of less than 12 g/dL, a lactate dehydrogenase level higher than normal, and/or a blood serum albumin levels of less than 3.5 g/dL are likely to have more an aggressive disease course and a shorter survival. However, even high-risk patients have even odds of living for five years after diagnosis. Some genetic mutations, such as mutations in NOTCH2, are also correlated with shorter survival.
Splenic marginal zone lymphoma
Nodal marginal zone B cell lymphoma
Hepatosplenic T-cell lymphoma
Primary mediastinal B-cell lymphoma
Marginal zone B-cell lymphoma
Pediatric-type follicular lymphoma
Duodenal-type follicular lymphoma
Diffuse infiltrative lymphocytosis syndrome